secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outlook Therapeutics, Inc. (OTLK)
CIK:        0001649989
Form:       8-K
Filed at:   2026-05-13T20:36:26+00:00
Accession:  0001104659-26-060305
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 1.02, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outlook Therapeutics enters new $100M ATM with H.C. Wainwright; cash at $7.7M
-----------------------------------------------------------------------------

- Entered into $100M at-the-market offering agreement with H.C. Wainwright & Co. as sales agent.
- Prior $100M ATM with BTIG terminated effective May 12, 2026.
- Preliminary cash and cash equivalents of $7.7M as of March 31, 2026 (unaudited), plus $4.5M from April 2026 direct offering.
- H.C. Wainwright will receive a 3% commission on gross proceeds from shares sold under the ATM.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649989/000110465926060305/0001104659-26-060305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649989/000110465926060305/tm2614480d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-060305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer